Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/27/2002 | WO2002102791A1 Pyrrolidine bicyclic compounds |
12/27/2002 | WO2002102790A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
12/27/2002 | WO2002102432A1 Biofunctional fibers |
12/27/2002 | WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma |
12/27/2002 | WO2002102310A2 Proteins associated with cell growth, differentiation, and death |
12/27/2002 | WO2002102299A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
12/27/2002 | WO2002102257A1 Apparatus for and methods of preparing sperm |
12/27/2002 | WO2002102235A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
12/27/2002 | WO2002102143A1 Transgenic animal transformed using green fluorescent protein gene |
12/27/2002 | WO2002095036A3 A novel intein and uses thereof |
12/27/2002 | WO2002090533A9 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells |
12/27/2002 | WO2002088330A3 Neural progenitor cells |
12/27/2002 | WO2002087626A9 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same |
12/27/2002 | WO2002081664A3 Use of nucleosides, nucleobases and derivatives thereof for improved production of adult stem cells |
12/27/2002 | WO2002066620A3 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
12/27/2002 | WO2002062973A3 Lipase variants |
12/27/2002 | WO2002057415A3 Method for altering cell fate |
12/27/2002 | WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals |
12/27/2002 | WO2002055720A9 Materials and methods relating to protein aggregation in neurodegenerative disease |
12/27/2002 | WO2002051994A3 Polypeptides |
12/27/2002 | WO2002036750A3 T-cells specifically recognizing minor histocompatibility antigen(s) and uses thereof for eliminating target cells |
12/27/2002 | WO2002029075A8 Multiple inducible gene regulation system |
12/27/2002 | WO2002029065A3 Retroviral vectors containing internal ribosomal entry sites |
12/27/2002 | WO2002012467A3 Drug metabolizing enzymes |
12/27/2002 | WO2002012279A3 Schizophrenia related gene and protein |
12/27/2002 | WO2002010414A3 Expression of biologically active polypeptides in duckweed |
12/27/2002 | WO2002010379B1 Modified cea and uses thereof |
12/27/2002 | WO2002008257A3 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
12/27/2002 | WO2002004623A3 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
12/27/2002 | WO2002004514A8 Compositions and methods for the therapy and diagnosis of lung cancer |
12/27/2002 | WO2001096390A3 Compositions and methods for the therapy and diagnosis of colon cancer |
12/27/2002 | WO2001094587A3 Extracellular messengers |
12/27/2002 | WO2001087935A9 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
12/27/2002 | WO2001085937A3 Regulator of g protein signalling (rgs8) |
12/27/2002 | WO2001085905A3 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
12/27/2002 | WO2001083715A8 Derivation of midbrain dopaminergic neurons from embryonic stem cells |
12/27/2002 | WO2001080865A9 Joint repair using mesenchymal stem cells |
12/27/2002 | WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof |
12/27/2002 | WO2001021767A9 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
12/27/2002 | WO2001011028A9 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof |
12/27/2002 | CA2465075A1 Hdac9 polypeptides and polynucleotides and uses thereof |
12/27/2002 | CA2455387A1 Fce fusion proteins for treatment of allergy and asthma |
12/27/2002 | CA2455254A1 Moraxella (branhamella) catarrhalis antigens |
12/27/2002 | CA2451465A1 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
12/27/2002 | CA2450845A1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
12/27/2002 | CA2450809A1 Methods for detecting and treating the early onset of aging-related conditions |
12/27/2002 | CA2450793A1 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
12/27/2002 | CA2450757A1 Methods for detection and separation of undifferentiated hepatic cells using dlk |
12/27/2002 | CA2450732A1 Stabilized proteins with engineered disulfide bonds |
12/27/2002 | CA2450652A1 Methods for cloning mammals using remodeling factors |
12/27/2002 | CA2450288A1 Novel human transporter proteins and polynucleotides encoding the same |
12/27/2002 | CA2450067A1 Proteins associated with cell growth, differentiation, and death |
12/27/2002 | CA2449978A1 Biofunctional fibers |
12/27/2002 | CA2448526A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
12/27/2002 | CA2446931A1 Pyrrolidine bicyclic compounds |
12/27/2002 | CA2446285A1 Fibroblast growth factor and nucleic acid encoding same |
12/27/2002 | CA2446284A1 Method for identification of agents for the treatment of diabetes |
12/27/2002 | CA2445261A1 Human tachykinin-related splice variants and compositions thereof |
12/27/2002 | CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
12/26/2002 | US20020199219 Modulation of abscisic acid signal transduction in plants |
12/26/2002 | US20020199213 Transgenic transchromosomal rodents for making human antibodies |
12/26/2002 | US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
12/26/2002 | US20020198366 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/26/2002 | US20020198168 Vaccine against Mycobacterial infections |
12/26/2002 | US20020198166 Method for treatment of cancer and infectious diseases and compositions useful in same |
12/26/2002 | US20020198154 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
12/26/2002 | US20020198149 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides; native membrane-bound proteins; PRO polypeptides |
12/26/2002 | US20020198148 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides; native membrane-bound proteins; PRO polypeptides |
12/26/2002 | US20020198147 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/26/2002 | US20020198143 B7-like polynucleotides, polypeptides, and antibodies |
12/26/2002 | US20020197719 Human and animal cell culture medium |
12/26/2002 | US20020197718 Method of providing a substrate with a ready-to-use, uniformly distributed extracellular matrix |
12/26/2002 | US20020197717 Human marrow stromal cell lines which sustain hematopoiesis |
12/26/2002 | US20020197716 Modified rapid expansion methods ("modified-REM") for in vitro propagation of T lymphocytes |
12/26/2002 | US20020197715 Culture system for mouse tracheal epithelial cells |
12/26/2002 | US20020197714 Composition and method for increasing cell density in cell cultures infected with lentivirus |
12/26/2002 | US20020197713 Cell-culture medium passes through the lumen of a hollow fiber and to pass nutrients through the walls of the hollow fiber to the cells in the extra-capillary space; rocking or rotation effects flow through gravity |
12/26/2002 | US20020197712 Polypeptide for use as tools in analyzing enzymatic gene expression |
12/26/2002 | US20020197710 Cell tube having two openings through which culture media can come in and out, said openings being eccentrically located on opposite end walls at corresponding positions in contact with the edge sides of the end walls. |
12/26/2002 | US20020197706 Mutant membrane protein for use in the treatment of defects in signal tranduction |
12/26/2002 | US20020197705 Mutant cells; for propagation of influenza virus mutants |
12/26/2002 | US20020197704 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering |
12/26/2002 | US20020197700 Receptor of the EDb-fibronectin domains |
12/26/2002 | US20020197693 Novel molecules of the card-related protein family and uses thereof |
12/26/2002 | US20020197678 Gene encoding MNR2 and uses thereof |
12/26/2002 | US20020197676 Novel chromophores/fluorophores and methods for using the same |
12/26/2002 | US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage |
12/26/2002 | US20020197674 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/26/2002 | US20020197671 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/26/2002 | US20020197666 Human chordin-related proteins and polynucleotides encoding them |
12/26/2002 | US20020197655 Antigen and monoclonal antibody which recognizes the antigen |
12/26/2002 | US20020197624 Expression vector for use as tool in genome analysis |
12/26/2002 | US20020197615 Nucleotide sequences coding polypeptide for use as diagnostic tool |
12/26/2002 | US20020197612 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects |
12/26/2002 | US20020197605 Novel Polynucleotides |
12/26/2002 | US20020197604 Extraction of preferential polypeptide from skin; obtain skin, remove preferential layer, extract preferential protein |
12/26/2002 | US20020197260 Molecular mimetics of unique neisseria meningitidis serogroup B epitopes |
12/26/2002 | US20020197258 Compositions and methods for preventing protein aggregation in neurodegenerative diseases |
12/26/2002 | US20020197255 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
12/26/2002 | US20020197243 Novel p53BP2 compounds for therapy and diagnosis and methods for using same |